Skip to content

Aquestive Therapeutics, Inc. AQST Other Income (Expense)

Discontinued — last reported Q3 '18

Other Income (Expense) at other companies

ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
-$473K-115%
Viatris logo
ViatrisVTRS
-$47.5M+52.2%
AMP
Amphastar PharmaceuticalsAMPH
-$3.58M+44.4%
AptarGroup logo
AptarGroupATR
-$53K-146%
Regenxbio logo
RegenxbioRGNX
-$6.69M-10.7%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$1.28M-16.0%

Segments

By segment

See full
Reportable Segment-$3.85M-8.1%

Other financials

Income statement

See full
Revenue$14.4M+65.7%
Gross profit$11.0M+117%
Operating income-$4.2M+78.3%
Net income-$8.1M+64.9%
EPS (diluted)-$0.07+70.8%

Balance sheet

See full
Cash & equivalents$110.7M+61.3%
Total debt$64.4M+7.4%
Total equity-$34.1M+44.1%
Total assets$141.1M+38.0%

Cash flow

See full
Operating cash flow-$14.8M+36.7%
CapEx$52.0K-61.5%
Free cash flow-$14.9M+36.9%

Valuation

See full
Market cap$560.13M+73.5%
Enterprise value$513.76M+63.6%
P/S11.1×+5.2×

Profitability

See full
Gross margin63.5%-4.9pp
Operating margin-111.2%+96.3pp
Net margin-137.1%+80.7pp
FCF margin-88.2%-2.2pp

Returns & leverage

See full
Return on equity145.1%
Debt / equity-1.9×
Current ratio4.1×-0.8×

Where this comes from

Reported directly by Aquestive Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherIncome.

The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed November 6, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.